Cell biology and clinical promise of G-CSF: Immunomodulation and neuroprotection: Cellular Medicine

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 6, 2007, Pages 1272-1290

  Xiao, Bao Guo ^a   Lu, Chuan Zhen ^a   Link, Hans ^b  

^a FUDAN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

G CSF; Immunomodulation; Neuroprotection

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOLOGIC FACTOR; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; BRAIN ISCHEMIA; HUMAN; IMMUNITY; NERVE DEGENERATION;

ANIMALS; BRAIN ISCHEMIA; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY; IMMUNOLOGIC FACTORS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS;

EID: 38149036410     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00101.x     Document Type: Article

References (113)

1. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996 88 : 1907 29.
2. + T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial. J Infect Dis. 2000 181 : 1148 52.
3. Klangsinsirikul P, Russell NH. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol. 2002 30 : 495 501.
4. Agnello D, Mascagni P, Bertini R, Villa P, Senaldi G, Ghezzi P. Granulocyte colony-stimulating factor decreases tumor necrosis factor production in whole blood: role of interleukin-10 and prostaglandin E(2). Eur Cytokine Netw. 2004 15 : 323 6.
5. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, d'Onofrio G, Leone G. Role for granulocyte colonystimulating factor in the generation of human T regulatory type 1 cells. Blood 2002 100 : 2562 71.
6. Pan L, Delmonte JJ, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colonystimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft- versus-host disease. Blood 1995 86 : 4422 9.
7. Hirayama Y, Sakamaki S, Matsunaga T, Kuroda H, Kusakabe T, Akiyama T, Kato J, Kogawa K, Koyama R, Nagai T, Ohta H, Niitsu Y. Granulocytecolony stimulating factor enhances the expression of transforming growth factor-beta mRNA in CD4-positive peripheral blood lymphocytes in the donors for allogeneic peripheral blood stem cell transplantation. Am J Hematol. 2002 69 : 138 40.
8. Kim SO, Sheikh HI, Ha SD, Martins A, Reid G. G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol. 2006 8 : 1958 71.
9. + regulatory T-cells. Diabetes 2005 54 : 78 84.
10. Morris ES, MacDonald KP, Rowe V, Johnson DH, Banovic T, Clouston AD, Hill GR. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood 2004 103 : 3573 81.
11. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 2004 64 : 8451 5.
12. high regulatory T cells. Blood 2004 104 : 895 903.
13. Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2000 95 : 2484 90.
14. Reddy V. Granulocyte colony-stimulating factor mobilization alters dendritic cell cytokine production and initiates T helper 2 polarization prior to host alloantigen presentation. Blood. 2000 96 : 2635.
15. Jun HX, Jun CY, Yu ZX. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colonystimulating factor. Haematologica 2004 89 : 1517 24.
16. Rutella S, Bonanno G, Pierelli L, Mariotti A, Capoluongo E, Contemi AM, Ameglio F, Curti A, De Ritis DG, Voso MT, Perillo A, Mancuso S, Scambia G, Lemoli RM, Leone G. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol. 2004 34 : 1291 302.
17. Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colonystimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood. 1998 92 : 215 22.
18. Fraser AR, Cook G, Franklin IM, Templeton JG, Campbell M, Holyoake TL, Campbell JD. Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity. J Leukoc Biol. 2006 80 : 862 9.
19. Saito M, Kiyokawa N, Taguchi T, Suzuki K, Sekino T, Mimori K, Suzuki T, Nakajima H, Katagiri YU, Fujimura J, Fujita H, Ishimoto K, Yamashiro Y, Fujimoto J. Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. Exp Hematol. 2002 30 : 1115 23.
20. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon- gamma. Blood. 2000 95 : 270 6.
21. + T-cell apoptosis following stem cell transplantation. Cancer Res. 1999 59 : 3107 11.
22. Morikawa K, Morikawa S, Nakamura M, Miyawaki T. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br J Haematol. 2002 118 : 296 304.
23. Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, Young NS. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood. 2000 95 : 2269 74.
24. Franzke A, Piao W, Lauber J, Gatzlaff P, Konecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood. 2003 102 : 734 9.
25. Gessler P, Neu S, Brockmann Y, Speer CP. Decreased mRNA expression of G-CSF receptor in cord blood neutrophils of term newborns: regulation of expression by G-CSF and TNF-alpha. Biol Neonate. 2000 77 : 168 73.
26. Zheng W, Flavell RA. The transcription factor GATA- 3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997 89 : 587 96.
27. Takemoto N, Kamogawa Y, Jun Lee H, Kurata H, Arai KI, O'Garra A, Arai N, Miyatake S. Cutting edge: chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J Immunol. 2000 165 : 6687 91.
28. Ranganath S, Ouyang W, Bhattarcharya D, Sha WC, Grupe A, Peltz G, Murphy KM. GATA-3- dependent enhancer activity in IL-4 gene regulation. J Immunol. 1998 161 : 3822 6.
29. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998 9 : 745 55.
30. van de Geijn GJ, Gits J, Touw IP. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling GCSF signaling. J Leukoc Biol. 2004 76 : 237 44.
31. Zhuang D, Qiu Y, Haque SJ, Dong F. Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1. J Leukoc Biol. 2005 78 : 1008 15.
32. Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, Cacalano N, O'Garra A, Oshida T, Saito H, Johnston JA, Yoshimura A, Kubo M. SOCS- 3 regulates onset and maintenance of TH2-mediated allergic responses. Nat Med. 2003 9 : 1047 54.
33. Yu CR, Mahdi RM, Ebong S, Vistica BP, Gery I, Egwuagu CE. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J Biol Chem. 2003 278 : 29752 9.
34. Li Y, Chu N, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol. 2006 177 : 1679 88.
35. Wong PK, Egan PJ, Croker BA, O'Donnell K, Sims NA, Drake S, Kiu H, McManus EJ, Alexander WS, Roberts AW, Wicks IP. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest. 2006 116 : 1571 81.
36. Jo D, Liu D, Yao S, Collins RD, Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med. 2005 11 : 892 8.
37. Ozaki A, Seki Y, Fukushima A, Kubo M. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J Immunol. 2005 175 : 5489 97.
38. Kimura A, Kinjyo I, Matsumura Y, Mori H, Mashima R, Harada M, Chien KR, Yasukawa H, Yoshimura A. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J Biol Chem. 2004 279 : 6905 10.
39. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002 8 : 500 8.
40. Zavala F, Abad S, Ezine S, Taupin V, Masson A, Bach JF. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J Immunol. 2002 168 : 2011 9.
41. Hadaya K, Kared H, Masson A, Chatenoud L, Zavala F. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J Autoimmun. 2005 24 : 125 34.
42. Egi H, Hayamizu K, Yoshimitsu M, Shimamoto F, Oishi K, Ohmori I, Okajima M, Asahara T. Regulation of T helper type-1 immunity in hapteninduced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine. 2003 23 : 23 30.
43. Brendolan A, Higuchi M, Sibley R, Strober S. Treatment of adjuvant arthritis with granulocytecolony stimulating factor and peptide derived from heat shock protein 65. Cell Immunol. 2003 221 : 6 14.
44. Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F, Renwick J, Brooks PM. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant. 1998 22 : 1035 41.
45. Vasiliu IM, Petri MA, Baer AN. Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares. J Rheumatol. 2006 33 : 1878 80.
46. Snir O, Lavie G, Achiron A, Bank I, Ben-Aharon T, Sredni B, Cohen IR, Mandel M. G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: a possible mechanism for exacerbation of multiple sclerosis. J Neuroimmunol. 2006 172 : 145 55.
47. Lawlor KE, Campbell IK, Metcalf D, O'Donnell K, van Nieuwenhuijze A, Roberts AW, Wicks IP. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc Natl Acad Sci USA. 2004 101 : 11398 403.
48. Verda L, Luo K, Kim DA, Bronesky D, Kohm AP, Miller SD, Statkute L, Oyama Y, Burt RK. Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis. Bone Marrow Transplant. 2006 38 : 453 60.
49. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and GCSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000 68 : 144 50.
50. Miyahara H, Hotokebuchi T, Saikawa I, Arita C, Takagishi K, Sugioka Y. The effects of recombinant human granulocyte colony-stimulating factor on passive collagen-induced arthritis transferred with antitype II collagen antibody. Clin Immunol Immunopathol. 1993 69 : 69 76.
51. Zavala F, Masson A, Hadaya K, Ezine S, Schneider E, Babin O, Bach JF. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J Immunol. 1999 163 : 5125 32.
52. Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colony-stimulating factor and neutrophils- forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol. 2006 2 : 500 10.
53. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005 115 : 2083 98.
54. Meuer K, Pitzer C, Teismann P, Kruger C, Goricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schabitz WR, Bach A, Schulz JB, Bahr M, Schneider A, Weishaupt JH. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem. 2006 97 : 675 86.
55. Cao XQ, Arai H, Ren YR, Oizumi H, Zhang N, Seike S, Furuya T, Yasuda T, Mizuno Y, Mochizuki H. Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels. J Neurochem. 2006 99 : 861 7.
56. Huang HY, Lin SZ, Kuo JS, Chen WF, Wang MJ. GCSF protects dopaminergic neurons from 6-OHDAinduced toxicity via the ERK pathway. Neurobiol Aging. 2007 28 : 1258 69.
57. Aloisi F, Care A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C. Production of hemolymphopoietic cytokines (IL-6, IL- 8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol. 1992 149 : 2358 66.
58. -/- astrocytes. Cytokine 2005 30 : 47 55.
59. Meeuwsen S, Persoon-Deen C, Bsibsi M, Ravid R, van Noort JM. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia. 2003. 43 : 243 53.
60. Wesselingh SL, Gough NM, Finlay-Jones JJ, McDonald PJ. Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res. 1990 9 : 177 85.
61. Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, Tateishi T, Ohyagi Y, Kira J. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2006 65 : 816 25.
62. Hasselblatt M, Jeibmann A, Riesmeier B, Maintz D, Schabitz WR. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 2007 113 : 45 51.
63. Kleinschnitz C, Schroeter M, Jander S, Stoll G. Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression. Brain Res Mol Brain Res. 2004 131 : 73 8.
64. Zhao LR, Navalitloha Y, Singhal S, Mehta J, Piao CS, Guo WP, Kessler JA, Groothuis DR. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol. 2007 204 : 569 73.
65. Six I, Gasan G, Mura E, Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol. 2003 458 : 327 8.
66. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001 32 : 1005 11.
67. Yanqing Z, Yu-Min L, Jian Q, Bao-Guo X, Chuan- Zhen L. Fibronectin and neuroprotective effect of granulocyte colony-stimulating factor in focal cerebral ischemia. Brain Res. 2006 1098 : 161 9.
68. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001 98 : 10344 9.
69. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002 59 : 514 23.
70. + progenitor cells after cardiac surgery. Circulation. 2006 114 : I186 92.
71. + cells. Int J Hematol. 2003 78 : 48 55.
72. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA. 1986 83 : 9231 5.
73. Tate MC, Shear DA, Hoffman SW, Stein DG, Archer DR, LaPlaca MC. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant. 2002 11 : 283 95.
74. Sakai T, Johnson KJ, Murozono M, Sakai K, Magnuson MA, Wieloch T, Cronberg T, Isshiki A, Erickson HP, Fassler R. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med. 2001 7 : 324 30.
75. Tom VJ, Doller CM, Malouf AT, Silver J. Astrocyteassociated fibronectin is critical for axonal regeneration in adult white matter. J Neurosci. 2004 24 : 9282 90.
76. Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, Hara H, Osaka A, Mochizuki H, Mizuno Y, Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab. 2006 26 : 402 13.
77. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, Ohtsuka M, Matsuura K, Sano M, Nishi J, Iwanaga K, Akazawa H, Kunieda T, Zhu W, Hasegawa H, Kunisada K, Nagai T, Nakaya H, Yamauchi-Takihara K, Komuro I. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005 11 : 305 11.
78. Ferrer I, Planas AM. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol. 2003 62 : 329 39.
79. Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Antiapoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience. 2006 143 : 965 74.
80. Jung KH, Chu K, Lee ST, Kang L, Kim SU, Kim M, Roh JK. G-CSF protects human cerebral hybrid neurons against in vitro ischemia. Neurosci Lett. 2006 394 : 168 73.
81. Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K, Takagi S, Okano H, Ando K, Hotta T. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation. 2006 113 : 701 10.
82. Natori T, Sata M, Washida M, Hirata Y, Nagai R, Makuuchi M. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun. 2002 297 : 1058 61.
83. Louissaint A Jr., Rao S, Leventhal C, Goldman SA. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 2002 34 : 945 60.
84. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 2003 22 : 319 29.
85. Takahama H, Minamino T, Hirata A, Ogai A, Asanuma H, Fujita M, Wakeno M, Tsukamoto O, Okada K, Komamura K, Takashima S, Shinozaki Y, Mori H, Mochizuki N, Kitakaze M. Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol- 3-kinase/Akt pathway in canine hearts. Cardiovasc Drugs Ther. 2006 20 : 159 65.
86. Peng Y, Jiang BH, Yang PH, Cao Z, Shi X, Lin MC, He ML, Kung HF. Phosphatidylinositol 3-kinase signaling is involved in neurogenesis during Xenopus embryonic development. J Biol Che. 2004 279 : 28509 14.
87. Vojtek AB, Taylor J, DeRuiter SL, Yu JY, Figueroa C, Kwok RP, Turner DL. Akt regulates basic helixloop- helix transcription factor-coactivator complex formation and activity during neuronal differentiation. Mol Cell Biol. 2003 23 : 4417 27.
88. Takagi Y, Omura T, Yoshiyama M, Matsumoto R, Enomoto S, Kusuyama T, Nishiya D, Akioka K, Iwao H, Takeuchi K, Yoshikawa J. Granulocytecolony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia. J Pharmacol Sci. 2005 99 : 45 51.
89. Lee M, Aoki M, Kondo T, Kobayashi K, Okumura K, Komori K, Murohara T. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Arterioscler Thromb Vasc Biol. 2005 25 : 2535 41.
90. Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood. 2006 108 : 2438 45.
91. Minamino K, Adachi Y, Okigaki M, Ito H, Togawa Y, Fujita K, Tomita M, Suzuki Y, Zhang Y, Iwasaki M, Nakano K, Koike Y, Matsubara H, Iwasaka T, Matsumura M, Ikehara S. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells. 2005 23 : 347 54.
92. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, Shimada K, Ogawa H, Daida H, Hattori K, Ohsaka A. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 2005 19 : 2005 7.
93. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003 111 : 1843 51.
94. Lu CZ, Xiao BG. G-CSF and neuroprotection: a therapeutic perspective in cerebral ischemia. Biochem Soc Trans. 2006 34 : 1327 33.
95. Gibson CL, Jones NC, Prior MJ, Bath PM, Murphy SP. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol. 2005 64 : 763 9.
96. Schneider A, Wysocki R, Pitzer C, Kruger C, Laage R, Schwab S, Bach A, Schabitz WR. An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol. 2006 4 : 36.
97. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ. 2006 174 : 927 33.
98. Borlongan CV, Hess DC. New hope for stroke patients: mobilization of endogenous stem cells. CMAJ. 2006 174 : 954 5.
99. Matchett GA, Calinisan JB, Matchett GC, Martin RD, Zhang JH. The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res. 2007 1136 : 200 7.
100. Henze C, Lescot T, Traver S, Salthun-Lassalle B, Hirsch EC, Michel PP, Hartmann A. Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro. Neurosci Lett. 2005 383 : 44 8.
101. Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E. Transplantation of bone marrow stem cells as well as mobilization by granulocytecolony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma. 2006 23 : 1379 91.
102. Sheibani N, Grabowski EF, Schoenfeld DA, Whalen MJ. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice. Crit Care Med. 2004 32 : 2274 8.
103. Hauben E, Agranov E, Gothilf A, Nevo U, Cohen A, Smirnov I, Steinman L, Schwartz M. Posttraumatic therapeutic vaccination with modified myelin selfantigen prevents complete paralysis while avoiding autoimmune disease. J Clin Invest. 2001 108 : 591 9.
104. Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol. 2007 184 : 100 12.
105. Gee JM, Kalil A, Shea C, Becker KJ. Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke. 2007 38 : 783 8.
106. + T cells. Exp Neurol. 2006 201 : 212 24.
107. + T cells following ischemic stroke. J Neurol Sci. 2005 233 : 125 32.
108. Hohlfeld R. Does inflammation stimulate remyelination J Neurol. 2007 254 : 147 54.
109. Squadrito F, Altavilla D, Squadrito G, Campo GM, Ioculano M, Ammedolia L, Arlotta M, Saitta A, Caputi AP. The effects of recombinant human granulocyte- colony stimulating factor on vascular dysfunction and splanchnic ischaemia-reperfusion injury. Br J Pharmacol. 1997 120 : 333 9.
110. Gorgen I, Hartung T, Leist M, Niehorster M, Tiegs G, Uhlig S, Weitzel F, Wendel A. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 1992 149 : 918 24.
111. Heard SO, Fink MP. Counterregulatory control of the acute inflammatory response: granulocyte colonystimulating factor has anti-inflammatory properties. Crit Care Med. 1999 27 : 1019 21.
112. Christopher MJ, Link DC. Regulation of neutrophil homeostasis. Curr Opin Hematol. 2007 14 : 3 8.
113. Dagia NM, Gadhoum SZ, Knoblauch CA, Spencer JA, Zamiri P, Lin CP, Sackstein R. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med. 2006 12 : 1185 90.